The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIMT.L Broker Ratings (IMT)

  • There is currently no data for IMT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Broker Recommendations for IMT.L (IMT)

Date Broker Recommendation Old Target New Target Rating Type
22-Mar-13NomuraReduce2,520.002,443.00Reiteration
22-Mar-13Credit SuisseOutperform2,700.002,700.00Reiteration
22-Mar-13Canaccord GenuityBuy2,900.002,900.00Reiteration
22-Mar-13Berenberg BankHold2,800.002,800.00Reiteration
21-Mar-13Bank of AmericaNeutral2,450.002,450.00Reiteration
20-Mar-13Oriel SecuritiesBuy2,900.002,900.00Reiteration
13-Mar-13NomuraReduce2,450.002,520.00Reiteration
08-Mar-13Goldman SachsNeutral2,440.002,470.00Reiteration

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.